Skip to content

Meaning Centered Psychotherapy for Palliative Care Patients (MCP-PC)

Development of Meaning Centered Psychotherapy for Palliative Care Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03612050
Acronym
MCP-PC
Enrollment
80
Registered
2018-08-02
Start date
2022-01-01
Completion date
2023-12-31
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative Care

Keywords

Palliative care, Despair, Spiritual well-being

Brief summary

This randomized, controlled trial evaluates the effectiveness of an adaptation of a well-established brief, structured existential psychotherapy (Meaning Centered Psychotherapy) specifically tailored to the needs of palliative care patients (MCP-PC). Terminally ill patients with cancer who have been hospitalized in a palliative care hospital will be randomly assigned to either MCP-PC or enhanced usual care. Patients will complete a very short battery of self-report measures before the 3-session intervention, and again 2 and 4 weeks later to determine whether treatment has bolstered spiritual and psychological well-being and improved quality of life.

Interventions

BEHAVIORALMeaning Centered Psychotherapy

Manualized, 3-session existential psychotherapy (30-45 minutes/session) with an optional 4th booster session. Content focuses on enhancing patients sense of meaning and purpose in life.

Sponsors

Calvary Hospital, Bronx, NY
CollaboratorOTHER
Fordham University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Terminal illness with life expectancy of less than 6 months; hospitalized at a palliative care facility in Bronx NY, English speaking

Exclusion criteria

* Cognitive impairment or severe psychiatric symptoms that preclude informed consent or participation in treatment.

Design outcomes

Primary

MeasureTime frameDescription
Spiritual Well BeingThrough study completion (approx 6 weeks)Overall spiritual well-being as measured through the self-report FACIT Spiritual Well Being scale

Secondary

MeasureTime frameDescription
HopelessnessThrough study completion (approx 6 weeks)Self-report rating scale, the Hopelessness Assessment in Illness scale
Acceptance of DeathThrough study completion (approx 6 weeks)Subscale derived from the Life Attitude Profile, a self-report measure of meaning and purpose
Health related Quality of lifeThrough study completion (approx 6 weeks)Single item rating of overall quality of life derived from the McGill Quality of Life Questionnaire
Desire for hastened deathThrough study completion (approx 6 weeks)Abbreviated version of the Schedule of Attitudes towards Hastened Death, a measure of desire for hastened death

Contacts

Primary ContactBarry D Rosenfeld, PhD
rosenfeld@fordham.edu718-817-3794

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026